BlackRock’s NRC Health Common Stock NRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.6M | Sell |
975,855
-29,468
| -3% | -$501K | ﹤0.01% | 3191 |
|
|
2025
Q4 | $18.9M | Sell |
1,005,323
-59,792
| -6% | -$902K | ﹤0.01% | 3136 |
|
|
2025
Q3 | $13.6M | Sell |
1,065,115
-127,601
| -11% | -$1.91M | ﹤0.01% | 3290 |
|
|
2025
Q2 | $20M | Buy |
1,192,716
+71,101
| +6% | +$961K | ﹤0.01% | 3019 |
|
|
2025
Q1 | $14.4M | Sell |
1,121,615
-84,839
| -7% | -$1.36M | ﹤0.01% | 3125 |
|
|
2024
Q4 | $21.3M | Buy |
1,206,454
+42,198
| +4% | +$800K | ﹤0.01% | 3019 |
|
|
2024
Q3 | $26.6M | Buy |
1,164,256
+80,339
| +7% | +$1.82M | ﹤0.01% | 2854 |
|
|
2024
Q2 | $24.9M | Buy |
1,083,917
+15,898
| +1% | +$490K | ﹤0.01% | 2843 |
|
|
2024
Q1 | $42.3M | Buy |
1,068,019
+2,434
| +0.2% | +$96.3K | ﹤0.01% | 2538 |
|
|
2023
Q4 | $42.2M | Buy |
1,065,585
+50,002
| +5% | +$2.09M | ﹤0.01% | 2588 |
|
|
2023
Q3 | $45.1M | Sell |
1,015,583
-62,228
| -6% | -$2.72M | ﹤0.01% | 2452 |
|
|
2023
Q2 | $46.9M | Buy |
1,077,811
+63,465
| +6% | +$2.79M | ﹤0.01% | 2525 |
|
|
2023
Q1 | $44.1M | Buy |
1,014,346
+26,792
| +3% | +$1.18M | ﹤0.01% | 2530 |
|
|
2022
Q4 | $36.8M | Buy |
987,554
+54,628
| +6% | +$2.11M | ﹤0.01% | 2680 |
|
|
2022
Q3 | $37.1M | Sell |
932,926
-26,604
| -3% | -$985K | ﹤0.01% | 2674 |
|
|
2022
Q2 | $36.7M | Buy |
959,530
+37,930
| +4% | +$1.37M | ﹤0.01% | 2699 |
|
|
2022
Q1 | $36.5M | Buy |
921,600
+3,053
| +0.3% | +$120K | ﹤0.01% | 2770 |
|
|
2021
Q4 | $38.1M | Buy |
918,547
+22,539
| +3% | +$980K | ﹤0.01% | 2845 |
|
|
2021
Q3 | $37.8M | Sell |
896,008
-14,717
| -2% | -$741K | ﹤0.01% | 2847 |
|
|
2021
Q2 | $41.8M | Sell |
910,725
-108,304
| -11% | -$5.15M | ﹤0.01% | 2818 |
|
|
2021
Q1 | $47.7M | Buy |
1,019,029
+732
| +0.1% | +$35.6K | ﹤0.01% | 2646 |
|
|
2020
Q4 | $43.5M | Buy |
1,018,297
+28,377
| +3% | +$1.46M | ﹤0.01% | 2562 |
|
|
2020
Q3 | $48.7M | Buy |
989,920
+32,572
| +3% | +$1.8M | ﹤0.01% | 2322 |
|
|
2020
Q2 | $55.7M | Buy |
957,348
+93,978
| +11% | +$4.96M | ﹤0.01% | 2187 |
|
|
2020
Q1 | $39.3M | Buy |
863,370
+21,650
| +3% | +$1.3M | ﹤0.01% | 2206 |
|
|
2019
Q4 | $55.5M | Buy |
841,720
+19,010
| +2% | +$1.16M | ﹤0.01% | 2299 |
|
|
2019
Q3 | $47.5M | Buy |
822,710
+112,762
| +16% | +$6.99M | ﹤0.01% | 2317 |
|
|
2019
Q2 | $40.9M | Buy |
709,948
+49,361
| +7% | +$2.28M | ﹤0.01% | 2442 |
|
|
2019
Q1 | $25.5M | Sell |
660,587
-32,803
| -5% | -$1.29M | ﹤0.01% | 2627 |
|
|
2018
Q4 | $26.4M | Sell |
693,390
-4,540
| -0.7% | -$174K | ﹤0.01% | 2577 |
|
|
2018
Q3 | $26.9M | Buy |
697,930
+103,348
| +17% | +$3.92M | ﹤0.01% | 2713 |
|
|
2018
Q2 | $22.2M | Buy |
594,582
+120,731
| +25% | +$4.21M | ﹤0.01% | 2790 |
|
|
2018
Q1 | $13.9M | Sell |
473,851
-2,428
| -0.5% | -$81.5K | ﹤0.01% | 2963 |
|
|
2017
Q4 | $17.8M | Buy |
476,279
+2,620
| +0.6% | +$93K | ﹤0.01% | 2843 |
|
|
2017
Q3 | $17.9M | Buy |
473,659
+12,687
| +3% | +$399K | ﹤0.01% | 2869 |
|
|
2017
Q2 | $12.4M | Buy |
460,972
+57,001
| +14% | +$1.39M | ﹤0.01% | 3053 |
|
|
2017
Q1 | $7.96M | Buy |
403,971
+403,089
| +45,702% | +$7.46M | ﹤0.01% | 3212 |
|
|
2016
Q4 | $17K | Buy |
882
+470
| +114% | +$7.76K | ﹤0.01% | 3294 |
|
|
2016
Q3 | $7K | Sell |
412
-602
| -59% | -$9.45K | ﹤0.01% | 3455 |
|
|
2016
Q2 | $14K | Buy |
1,014
+602
| +146% | +$8.49K | ﹤0.01% | 3348 |
|
|
2016
Q1 | $6K | Buy |
+412
| New | +$6.04K | ﹤0.01% | 3324 |
|
Other funds holding NRC
VCM
QI
BlackRock's NRC Position: Q1 2026 in Review
BlackRock reduced its NRC Health Common Stock (NRC) stake by 2.9% in Q1 2026, selling an estimated $501K and leaving 975,855 shares worth $16.6M. The position accounts for ﹤0.01% of the portfolio, ranked #3191.
BlackRock first reported a position in NRC in Q1 2016 and has held it in 41 quarters since. The position peaked at $55.7M in Q2 2020. 121 funds tracked by Wall St. Rank hold NRC as of Q1 2026.
- BlackRock held 975,855 shares of NRC Health Common Stock worth $16.6M as of Q1 2026.
- BlackRock sold 29,468 NRC Health Common Stock shares in Q1 2026, an estimated $501K.
- NRC Health Common Stock made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #3191 holding.
- BlackRock first reported a position in NRC Health Common Stock in Q1 2016 and has held it in 41 quarters since.
- BlackRock's NRC Health Common Stock position peaked at $55.7M in Q2 2020.
- 121 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2026.
Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.